Jessner's Peel: Step-by-Step Clinical Protocol & Indications

Jessner's solution is one of the oldest formulations still in everyday clinical use, and it survives for a single reason: it is forgiving. Where trichloroacetic acid stakes its depth in one irreversible step and high-strength glycolic acid runs on a clock you cannot pause, Jessner's lets you titrate injury one coat at a time — applying, reading the skin, and deciding whether to stop or layer again. That coat-by-coat control is precisely what makes it a workhorse in Fitzpatrick IV–VI skin, where over-penetration is not an inconvenience but a pigmentary complication that can outlast the original complaint.

This guide walks the composition, mechanism, the coat-based application that defines the peel, expected endpoints, the real indications, and — woven throughout — how the formula and technique change when the patient in your chair is a brown-skinned Indian patient at genuine risk of post-inflammatory hyperpigmentation (PIH).

What Jessner's Solution Actually Is

Classic Jessner's solution is a tri-acid keratolytic in an ethanol base. The canonical formula, attributed to Max Jessner, combines three agents at equal concentration:

• Resorcinol 14% — a phenol derivative, keratolytic and antiseptic
• Salicylic acid 14% — a lipophilic beta-hydroxy acid that penetrates the follicular unit
• Lactic acid 14% — an alpha-hydroxy acid that loosens corneocyte cohesion

DermNet and standard procedural-dermatology references describe Jessner's as a superficial peel whose three components act synergistically to break intercellular bridges in the stratum corneum, so the depth of a single coat is shallow but the keratolysis is broad. Prodermic's 460 Jessner peel is a modified tri-acid system built on the same resorcinol–lactic–salicylic logic — important to flag up front, because "Jessner's" in 2026 rarely means the original phenol-heavy recipe.

Mechanism and How Coats Titrate Depth

Each acid contributes a distinct action. Salicylic acid is lipophilic and concentrates in sebaceous follicles, giving Jessner's its comedolytic and anti-inflammatory edge in acne. Lactic acid disrupts corneocyte adhesion and draws water, softening the stratum corneum. Resorcinol, structurally similar to phenol, adds keratolysis and a mild antibacterial effect. Because the agents are co-formulated, a single coat achieves more uniform keratolysis than any one acid alone at the same strength.

Depth scales with coats applied and degreasing quality, not contact time:

• 1 coat — very superficial; erythema, light powdery residue
• 2 coats — superficial; faint, blotchy pseudo-frost begins
• 3–4 coats — deeper superficial; more even white pseudo-frost (a salicylic-acid crystalline deposit, not the protein-coagulation frost of TCA)

The distinction between Jessner's pseudo-frost and TCA's true frost is not pedantic. TCA frost signals coagulated dermal protein and a fixed injury depth; Jessner's "frost" is largely precipitated salicylic acid on the surface — wipeable, and not in itself a marker of dermal injury. Reading the two as equivalent is a classic novice error that leads to under- or over-treatment. For the full superficial-to-deep map of where Jessner's sits relative to other agents, see understanding chemical peel depths.

Expected Endpoints

The endpoint you are titrating toward depends on indication and skin type, but the progression is consistent:

1. Erythema after the first coat — the baseline response.
2. Blotchy, uneven pseudo-frost after the second coat — speckled white deposit.
3. More confluent pseudo-frost by the third or fourth coat — the practical ceiling for most superficial Jessner's protocols.

In darker skin you frequently stop at erythema or a faint, patchy frost — chasing a confluent endpoint in Fitzpatrick V–VI is how clinicians manufacture PIH. The endpoint is a clinical decision keyed to the patient, never a fixed target you owe the protocol.

Indications

Jessner's earns its place across several presentations, and its multi-acid breadth is the reason:

• Acne — comedonal and inflammatory. The salicylic component's follicular penetration makes Jessner's a strong acne peel; the modified 460 Jessner peel is positioned exactly here. For milder or first-time acne patients, a single-agent S30 salicylic peel is a gentler entry point before escalating to the tri-acid formula.
• Melasma and dyschromia. Jessner's improves epidermal pigment via keratolysis and enhanced turnover, though it is rarely a stand-alone melasma solution and works best inside a multi-pathway depigmentation strategy.
• Photoaging. Fine lines, dullness, and rough texture respond to the superficial resurfacing; deep rhytides do not — set that expectation explicitly.
• Post-inflammatory hyperpigmentation. Useful, but with the central caveat that the peel used to treat PIH can also trigger it if pushed too deep.
• As a prime before TCA (combination peel). This is one of Jessner's most valuable roles. A coat or two of Jessner's before medium-depth TCA evens penetration and lowers the demarcation risk — the Monheit combination peel pairs Jessner's with 35% TCA for exactly this reason. We cover the partner side of that protocol in the TCA peel strengths guide.

The India / Fitzpatrick IV–VI Lens

This is where Jessner's protocol genuinely diverges from the Western textbook, and where most generic guides go quiet.

Resorcinol is the problem child. The original 14% resorcinol load carries two liabilities that matter disproportionately in Indian practice: a real rate of allergic and irritant contact sensitisation, and — with repeated or occluded exposure — historical reports of resorcinol's effect on thyroid function and, rarely, ochronosis-like pigmentation. In pigment-prone skin, the inflammation resorcinol can provoke is itself a PIH driver. This is why modified, resorcinol-free Jessner's formulations were developed.

The most cited alternative is the modified Jessner's of Bridenstine — resorcinol replaced by citric acid, retaining lactic and salicylic acid. Indian Journal of Dermatology, Venereology and Leprology literature on peels in skin of colour repeatedly favours such resorcinol-free, lower-irritancy formulations for Fitzpatrick IV–VI precisely to keep the inflammatory load — and therefore the PIH risk — down. If you treat predominantly brown skin, a resorcinol-free tri-acid should be your default, not your exception.

Three further rules govern Jessner's in deeply pigmented skin:

1. Prime first. Two to four weeks of a topical retinoid plus a tyrosinase-directed agent (hydroquinone 4% or a kojic-based depigmenter) thins and evens the corneum, pacifies melanocytes, and screens out hyper-reactors. The same priming discipline applies as for any medium-depth peel in this population.
2. Fewer coats, lower endpoint. Stop at erythema or faint frost; do not chase confluence.
3. Slower cadence. Space sessions to allow full inflammatory quieting between treatments.

For the broader framework on preventing and managing pigment sequelae in this population, Jessner's sits inside the same prevention-first logic as every other peel we run in brown skin.

A Fitzpatrick-Keyed Starting Frame

These are conservative starting points for a first Jessner's session, titrated up only across subsequent visits and only if tolerance is clean.

Fitzpatrick	Formula preference	First-session coats	Target endpoint	Notes
I–III	Classic or modified	2–3 coats	Light–even pseudo-frost	Frost readable; standard candidate
IV	Resorcinol-free preferred	1–2 coats	Erythema → faint frost	Prime mandatory; watch malar zone
V–VI	Resorcinol-free	1–2 coats	Erythema only	Prime mandatory; stop early, slow cadence

Application: Step by Step

1. Degrease thoroughly. Cleanse and remove all surface oil — uneven degreasing is the leading cause of patchy, unpredictable coats. A dedicated pre-peel cleanser standardises this step across operators.
2. Protect sensitive zones. Petrolatum on the nasal alae, oral commissures, and canthi.
3. Apply the first coat in a fixed sequence — forehead, cheeks, chin, nose — with gauze, a cotton-tipped applicator, or a brush. Use even, slightly overlapping strokes.
4. Read the skin, then decide. Wait for erythema and any developing pseudo-frost to declare itself before layering. Add a second (and, if indicated and tolerated, a third) coat only when the endpoint for this patient has not been reached.
5. Stop at the endpoint — for FST IV–VI, that is usually one to two coats.

Neutralisation and Post-Peel Care

Jessner's is self-limiting: the salicylic component crystallises and the keratolysis is broad but shallow, so it does not require active chemical neutralisation the way buffered glycolic acid does. It is left on, the patient washes it off at home after the prescribed interval, or it is gently rinsed in clinic. That said, when Jessner's is used as a prime before TCA, the relevant neutralisation belongs to the TCA stage of the combination peel — keep your neutraliser and cool-water compresses staged and ready for that step.

Post-peel care mirrors any superficial resurfacing: broad-spectrum SPF 50+ is non-negotiable for at least four weeks (post-peel sun exposure is itself a PIH trigger), bland ceramide-based moisturiser to support re-epithelialisation, and an active-ingredient holiday — pause retinoids, AHAs, and vitamin C for roughly five to seven days. Light, flaky desquamation over three to five days is expected; deep peeling means you layered more coats than the skin needed.

Contraindications and Complications

Contraindications:

• Resorcinol sensitivity — a hard contraindication for classic Jessner's; switch to a resorcinol-free formula.
• Salicylate allergy — given the salicylic acid load, a salicylate-allergic patient should not receive Jessner's.
• Pregnancy and lactation — salicylic acid is generally avoided in pregnancy; defer pending obstetric sign-off.
• Active cutaneous infection (bacterial, herpetic, fungal), a compromised or eroded barrier, and recent isotretinoin. Active herpes labialis warrants antiviral prophylaxis given the flare risk.

Complications: transient erythema, stinging, dryness, and expected flaking are routine. The complication that matters in pigmented skin is PIH, which is largely preventable through resorcinol-free formula selection, priming, conservative coats, and rigorous photoprotection. Resorcinol-specific risks — contact sensitisation and, with chronic exposure, systemic effects — are an additional reason FST IV–VI protocols default to the resorcinol-free version. Prolonged erythema, blistering, and hypopigmentation are uncommon but reported, almost always from over-layering.

Key Takeaways

1. Jessner's is coat-titrated, not time-titrated. Depth scales with coats layered; one coat is very superficial, three to four reach the deeper end of superficial.
2. Pseudo-frost is not TCA frost. It is precipitated salicylic acid that wipes off — never push coats to "deepen" it the way you would drive TCA to a Level III endpoint.
3. In Fitzpatrick IV–VI, go resorcinol-free and stop early. Use a modified formula, prime for 2–4 weeks, apply one to two coats, and target erythema rather than confluent frost.
4. Its highest-value role is often as a prime before TCA. A coat or two evens penetration and lowers demarcation risk in combination peels.
5. PIH is preventable, not inevitable. Formula selection, priming, conservative coats, and SPF 50+ are the levers that keep pigmented skin safe.